IL6 and rheumatoid arthritis: Among the different inflammatory soluble factors, interleukin-6 (IL-6), a pleiotropic mediator with a pivotal role in RA pathogenesis, exerts potent immunomodulatory effects on the balance between Th17 cells and CD4posCD25posFoxP3pos regulatory T lymphocytes in RA patients [11].